Hypermarcas (OTCMKTS:HYPMY) Shares Gap Up – Here’s What Happened

Hypermarcas (OTCMKTS:HYPMY)’s stock price gapped up before the market opened on Tuesday . The stock had previously closed at $4.12, but opened at $4.2725. Hypermarcas shares last traded at $4.35, with a volume of 234 shares changing hands.

Analyst Ratings Changes

Separately, Jefferies Financial Group upgraded shares of Hypermarcas to a “strong-buy” rating in a report on Monday, July 20th. One analyst has rated the stock with a Strong Buy rating and one has assigned a Hold rating to the company. According to data from MarketBeat.com, Hypermarcas has an average rating of “Buy”.

Hypermarcas Trading Up 1.6%

The stock has a market capitalization of $3.08 billion, a P/E ratio of 8.74 and a beta of 0.71. The stock has a 50 day moving average of $4.13 and a 200-day moving average of $4.29.

Hypermarcas (OTCMKTS:HYPMY) last posted its quarterly earnings data on Thursday, August 6th. The company reported $0.14 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.13 by $0.01. Hypermarcas had a return on equity of 14.63% and a net margin of 19.77%. Research analysts anticipate that Hypermarcas will post 0.53 EPS for the current year.

Hypermarcas Company Profile

Hypermarcas SA is a Brazil-based consumer health and pharmaceutical company whose shares trade over the counter in the United States under the symbol HYPMY. Founded in the early 2000s and headquartered in Rio de Janeiro, the company operates as a holding group for a broad portfolio of branded products in the healthcare and personal care sectors.

Through its various subsidiaries, Hypermarcas develops, manufactures and markets prescription and over-the-counter medications, alongside personal care, baby care, home care and nutritional supplement products.